Turkish USIQ: Validity & Reliability

Sponsor
Izmir Democracy University
Study ID
NCT07452796
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Overactive Bladder

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • Observational Cohort — OTHER
    Women diagnosed with Overactive Bladder (OAB) attending the Gynecology and Oncology Clinic at Buca Seyfi Demirsoy Training and Research Hospital who meet inclusion and exclusion criteria. Participants will complete demographic and clinical questionnaires, including USIQ, IIQ-7, UDI-6, and OAB-q. Test-retest reliability will be assessed in a subgroup after 14 days.

Study Details

The Urgency, Severity, and Impact Questionnaire (USIQ) assesses urinary urgency independently of incontinence, measuring both symptom severity and its impact on quality of life. While validated in English and Hebrew populations, a Turkish version has not yet been developed. This study aims to adapt USIQ for the Turkish population and evaluate its psychometric properties, providing a standardized, culturally relevant tool for clinical and research use.

Key Dates

First listed
Mar 5, 2026
Start date
Apr 15, 2026
Status verified
Mar 2026
Primary completion
Jul 15, 2027
Completion
Nov 15, 2027

Study Design

Enrollment
130 participants (estimated)

Arms

  • Arm: Observational Cohort
    Women diagnosed with Overactive Bladder (OAB) attending the Gynecology and Oncology Clinic at Buca Seyfi Demirsoy Training and Research Hospital who meet inclusion/exclusion criteria.

Primary Outcome Measure

Urgency, Severity and Impact Questionnaire (USIQ) [ Time Frame: At Baseline ]

Central Contacts

Related Studies